Medical research

The potential and challenges of mucosal COVID-19 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop ...

Medical research

How human challenge trials accelerate vaccine development

Anna Durbin was in Brazil in December 2015 when the Zika virus erupted in the country's northeast. Although she'd flown to São Paulo to work on a dengue vaccine, Durbin returned to Baltimore preoccupied with Zika.

Vaccination

BioNTech mobile mRNA vaccine labs reach Rwanda

Six mobile vaccine production units by German pharma company BioNTech arrived in Rwanda on Monday, the first such shipments to Africa as the continent seeks to boost mRNA vaccine manufacturing.

Diseases, Conditions, Syndromes

President Biden to end COVID-19 emergencies on May 11

President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing COVID-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first ...

page 4 from 34